Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Feng Lu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Biomedical Science|June 28, 2023
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concernMonika Kumari, Shih-Chieh Su, Kang-Hao Liang, et al.
Vaccine|May 15, 2025
Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residueMonika Kumari, Shih-Chieh Su, Hsiu-Ting Lin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 18, 2013
DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinomaYu-Zheng Xue, Tie-Long Wu, Yan-Min Wu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 19, 2012
Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significanceYu-Zheng Xue, Ying-Yue Sheng, Zong-Liang Liu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Biomedical Science|June 28, 2023
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concernMonika Kumari, Shih-Chieh Su, Kang-Hao Liang, et al.
Vaccine|May 15, 2025
Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residueMonika Kumari, Shih-Chieh Su, Hsiu-Ting Lin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 18, 2013
DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinomaYu-Zheng Xue, Tie-Long Wu, Yan-Min Wu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 19, 2012
Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significanceYu-Zheng Xue, Ying-Yue Sheng, Zong-Liang Liu, et al.
Pageof 2